Crunchbase News

APRIL 19, 2024

Metsera , $290M, biotech: This week was a slower week than normal for biotech — as it was for most sectors — but that didn’t stop New York-based Metsera. The company develops power-optimized chips targeting the data analytics and generative AI markets. In fact, it only took raising about $30 million-plus to make the list.

Biotech 102

Biotech Generative AI Artificial Intelligence Artificial Inteligence 102

Crunchbase News

MARCH 1, 2024

The quintet that did raise big were from three of the usual sectors — biotech, energy and AI — however one was from a sector we don’t normally see — a vertical farming agtech startup. Fervo Energy, a geothermal developer, locked up a big $244 million round led by shale oil and gas firm Devon Energy Corp.

Energy 92

Energy Biotech Artificial Intelligence Artificial Inteligence 92

TechCrunch

NOVEMBER 22, 2022

Artificial intelligence has become ubiquitous in clinical diagnosis. “We see ourselves building the foundational layer of artificial intelligence in healthcare. Healthtech startup RedBrick AI has raised $4.6 But researchers need much of their initial time preparing data for training AI systems.

Artificial Inteligence 234

Artificial Inteligence Artificial Intelligence Biotech 3D 234

Crunchbase News

MARCH 29, 2024

While there were no huge rounds like last week, money was again spread around from AI to biotech to marketing and more. Earlier in March, shares of Astera Labs — a developer of data center connectivity technology with use cases in generative AI — soared after its initial public offering on the Nasdaq.

Biotech 102

Biotech Artificial Intelligence Artificial Inteligence Energy 102

Crunchbase News

MARCH 5, 2024

Figure , $675M, artificial intelligence: Sunnyvale, California-based Figure last week confirmed earlier reports that it had raised a huge $675 million round at a $2.6 The company is developing AI-enhanced robots that it hopes will be able to perform dangerous jobs and alleviate labor shortages. billion, per Crunchbase.

Games 77

Games Artificial Intelligence Artificial Inteligence Biotech 77

Crunchbase News

FEBRUARY 2, 2024

Kore.ai , $150M, artificial intelligence: Another week and another big round for a generative AI startup. The startup is not new to the AI scene — it’s a decade old — and offers an array of artificial intelligence-related tech from virtual assistants to no-code tools to build AI apps. billion, per Crunchbase.

Biotech 76

Biotech Artificial Intelligence Artificial Inteligence Pharmaceuticals 76

Crunchbase News

MARCH 15, 2024

Applied Intuition , $250M, autonomous vehicles: Autonomous vehicle software developer Applied Intuition locked up a $250 million Series E valuing the company at $6 billion — a 67% uptick in value from its previous round. Like many biotech startups raising big money currently, Zephyr is bringing AI to the sector.

Biotech 91

Biotech Artificial Intelligence Artificial Inteligence Cloud 91

TechCrunch

AUGUST 15, 2022

In addition to biotech, Russek felt there also needed to be software and automation components. Finally, artificial intelligence-powered automation and engineering components are designed to remote-monitor the water quality, regulate temperature and oxygenation and feed the shrimp. So they created Atarraya, a U.S.-based

Technology 238

Technology Biotech Artificial Intelligence Artificial Inteligence 238

Crunchbase News

DECEMBER 8, 2023

Rockville, Maryland-based X-energy, a developer of advanced small modular nuclear reactors and fuel technology for clean energy, completed its Series C financing that totaled $235 million. X.AI , $135M, artificial intelligence: You may have heard Elon Musk has an artificial intelligence startup to compete with OpenAI.

Energy 64

Energy Artificial Inteligence Biotech Artificial Intelligence 64

Crunchbase News

FEBRUARY 7, 2024

The company — a utility-scale solar and energy storage project development, ownership and operations platform — will use the new capital to grow its “high value project development pipeline.” Kore.ai , $150M, artificial intelligence: Of course there’s a big round for a generative AI startup. billion in October 2022.

Energy 76

Energy Biotech Artificial Intelligence Artificial Inteligence 76

TechCrunch

DECEMBER 2, 2020

Sifting through the trillions of molecules out there that might have powerful medicinal effects is a daunting task, but the solution biotech has found is to work smarter, not harder. We will be hiring more top notch AI researchers, software engineers, medicinal chemists and biotech talent, as well as building our own research labs.”

Biotech 265

Biotech 3D Artificial Inteligence Machine Learning 265

Crunchbase News

MARCH 11, 2024

Last month, a16z seemed to have a thing for healthcare and biotech. The firm took part in a $70 million Series B for San Francisco-based Ambience Healthcare , a $170 million Series D for Richmond, California-based BioAge Labs and a huge $254 million round for South San Francisco-based blood-test developer Freenome.

Biotech 89

Biotech Artificial Intelligence Artificial Inteligence Healthcare 89

Crunchbase News

FEBRUARY 15, 2024

Money still coming Investors in the space — which is broad and includes several areas of sectors such as biotech, manufacturing and climate tech — agree that while there has undoubtedly been a slow down in investing, the wide breadth of deep tech and the importance of the problems it is looking to solve has kept money flowing.

Biotech 92

Biotech Artificial Intelligence Artificial Inteligence Energy 92

Existek

SEPTEMBER 28, 2023

With the major progress in all sub-domains of artificial intelligence, the demand for AI developers has tremendously increased. Moreover, the involvement of AI developers has been proven to play a prominent role in delivering sophisticated products and services. List of the Content What do AI developers do?

Artificial Inteligence 52

Artificial Inteligence Development How To Artificial Intelligence 52

Crunchbase News

APRIL 3, 2024

Others include: Imbue , a startup that trains foundational models to develop AI agents, landed $200 million in a September Series B round at a valuation of more than $1 billion. San Francisco-based Replit , a developer platform that uses AI to complete code, has raised $222 million in known funding at a valuation of at least $1.2

Artificial Intelligence 112

Artificial Intelligence Artificial Inteligence CTO Coach Technical Review 112

CIO

SEPTEMBER 18, 2023

The latest piece in her reinvention story is Synchrony’s new Tech Apprenticeship for Artificial Intelligence, a full-time, 12-month program that balances on-the-job learning with instructor-led training, providing Chavarin with a pathway into one of the most coveted technology spaces despite her very nontraditional IT background.

Technical Review 340

Technical Review Pharmaceuticals Security Training 340

TechCrunch

MAY 20, 2022

With cloud-based servers and sophisticated, yet inexpensive, sensors both on the body and off, patients can be monitored at home more effectively than in a hospital, especially when the sensor data is analyzed with artificial intelligence (AI) and machine-learning technology. Opportunities for digital biomarkers.

Artificial Inteligence 231

Artificial Inteligence Artificial Intelligence Healthcare Technical Review 231

Crunchbase News

JANUARY 26, 2024

The company — a utility-scale solar and energy storage project development, ownership and operations platform — will use the new capital to grow its “high value project development pipeline.” tied) Accent Therapeutics , $75M, biotech: Another week, another big biotech round.

Energy 86

Energy Biotech Pharmaceuticals Fintech 86

TechCrunch

MAY 26, 2021

So a new crop of biotech companies have worked to integrate these aspects. “Next year, we anticipate having our first drug candidate enter the late preclinical phase of development and regulatory work for an IND (investigational new drug) filing with the FDA, and starting the clinical trials in 2023.”

Engineering 248

Engineering Biotech Chemicals Artificial Inteligence 248

TechCrunch

APRIL 19, 2022

The three met while working together at Leap Motion, the now-defunct startup developing motion sensors for desktops and augmented reality headsets. But [I] had a pharmaceutical industry background and it soon became apparent that there had been no investment in machine learning as a technology for pharma development,” Fisher said.

Pharmaceuticals 170

Pharmaceuticals Artificial Inteligence Development Machine Learning 170

Crunchbase News

DECEMBER 20, 2023

Some think such a development could be the next advancement of AI, since human neurons have some advantages over their digital counterparts. If all that is not terrifying enough, In-Q-Tel — the venture capital arm of the Central Intelligence Agency — is an investor. The cash valued the climate-tech startup at $1.15

Biotech 106

Biotech Artificial Intelligence Artificial Inteligence Energy 106

Crunchbase News

JANUARY 8, 2024

In addition to AI, cleantech, biotech and next-generation manufacturing were among the areas where startups scored outsized rounds. For the fourth quarter, the largest early-stage rounds hailed from the biotech space. This past quarter, for instance, Elon Musk ’s artificial intelligence startup xAI picked up $134.7

Biotech 93

Biotech Generative AI Insurance Artificial Intelligence 93

TechCrunch

APRIL 23, 2021

A biotech company that has spent 11 years researching supplements to increase human longevity plans to launch its supplements later this year. PayPal co-founder Peter Thiel invested in Unity Biotechnology , which is developing drugs to treat diseases that accompany aging. And Ethereum founder Vitalik Buterin invested $2.4

Research 261

Research Biotech Nonprofit Comparison 261

Crunchbase News

DECEMBER 21, 2023

Artificial intelligence was big in 2023 — and that could be the understatement of the year. The round was led by Innovation Park Artificial Intelligence , Bosch Ventures and the companies of Schwarz Group. Founded in 2019, Aleph Alpha allows companies to develop and deploy large language and multimodal models.

Artificial Inteligence 117

Artificial Inteligence Artificial Intelligence Generative AI Biotech 117

Crunchbase News

FEBRUARY 23, 2024

Recogni , $102M, artificial intelligence: Although most startup chipmakers have not seen much love from investors so far this year , Recogni seems to have bucked that trend. Hornblower also announced a reshuffling of some of its units, including trying to sell its overnight cruising business. Clearly a lot is going on.

Artificial Intelligence 91

Artificial Intelligence Artificial Inteligence Energy Backup 91

Crunchbase News

FEBRUARY 16, 2024

AI-enabled healthcare There’s a lot of funding for nascent companies at the intersection of artificial intelligence and healthcare. New York-based Jona wants to use artificial intelligence to uncover links between the microbiome and health. Without further ado, here are five of our top trends for seed-stage.

Construction 110

Construction Artificial Intelligence Artificial Inteligence Generative AI 110

TechCrunch

AUGUST 10, 2022

Hong Kong-based drug discovery and development company Insilico has secured fresh capital at a time that its CEO described as a “biotech winter.” ” The firm has raised $35 million on the heels of its last tranche in June , bringing its total Series D investment to $95 million.

Chemicals 187

Chemicals Biotech Artificial Inteligence Pharmaceuticals 187

TechCrunch

DECEMBER 28, 2021

Deep tech, medtech/biotech, climate tech, and crypto and blockchain are all areas that investors say they’re either actively investing in or watching for signs of scale. Outset-backed Zenno Astronautics, for example, is developing a fuel-free satellite propulsion system that uses magnets powered by solar panels.

Technical Review 236

Technical Review Blockchain Biotech Software Review 236

TechCrunch

APRIL 6, 2022

6 questions investors should ask when evaluating psychedelic biotech companies. With plans to raise a $25 million fund and more than $15 million already invested, PsyMed Ventures focuses on early-stage startups developing psychedelic therapeutics. 6 questions investors should ask when evaluating psychedelic biotech companies.

Marketing 235

Marketing Biotech Retail 3D 235

TechCrunch

SEPTEMBER 8, 2022

To develop a commercially viable DNA storage platform, Catalog is reducing the amount of chemistry and increasing the amount of automation required for DNA storage and computation. The size of Shannon is like an average family kitchen, according to Catalog.

Storage 206

Storage Artificial Inteligence Data Artificial Intelligence 206

Crunchbase News

APRIL 15, 2024

Healthcare and Biotech IntraBio , a biopharmaceutical company developing treatments for neurodegenerative diseases raised a further $40 million in funding at a value of $1 billion. The 15-year-old company was valued at $1.1 Previously based in Oxford, the company has set up new headquarters in Austin, Texas.

Real Estate 94

Real Estate Blockchain Biotech Energy 94

TechCrunch

NOVEMBER 18, 2021

The drug development space is continuing to attract more and more investment. Generate Biomedicines is touting a platform-based approach to drug development, but with its own spin: a focus on proteins. . Meanwhile, investment in AI-based drug development has also snowballed. Per a Stanford University 2020 report, it reached $13.9

Artificial Inteligence 211

Artificial Inteligence Artificial Intelligence Machine Learning Report 211

TechCrunch

FEBRUARY 22, 2022

The world’s labs are under pressure to do more tests and process more materials, not just due to COVID but from the growing biotech and drug development sectors — and automation is the sure path forwards. When we last talked with Automata in 2019 , the company had just raised a $7.4M

Hardware 216

Hardware Biotech Technical Review Systems Review 216

TechCrunch

JANUARY 31, 2022

It’s also a key pillar of Gandeeva, a new biotech company that emerged from stealth on Monday with a $40 million Series A round. Meanwhile, there are other developments in structural biology working in Gandeeva’s favor. Cryogenic electron microscopy was formerly known for delivering amorphous images of biomolecules.

Artificial Inteligence 231

Artificial Inteligence Machine Learning Biotech Government 231

TechCrunch

OCTOBER 20, 2021

Healx is one of a host of startups invested in using AI for drug development and identification. AI-based drug development is becoming a bigger piece of the AI landscape. Funding for AI-based drug development skyrocketed to $13.5 Healx’s approach happens to be artificial intelligence. .

Artificial Inteligence 243

Artificial Inteligence Study Artificial Intelligence Pharmaceuticals 243

TechCrunch

DECEMBER 15, 2021

Prellis Biologics , a company developing the tools to create 3D-printed organs, announced a $14.5 Prellis has spent years developing tissue engineering capacity, but has focused recently on developing one type of structure in particular. Matheu calls it “natural intelligence” as opposed to artificial intelligence. .

System 203

System Artificial Inteligence 3D Pharmaceuticals 203

TechCrunch

APRIL 12, 2022

Prior to joining Lyft, Umare was a senior software engineer at Amazon and a principal engineer at Oracle, where he led development of a block storage product for an infrastructure-as-a-service and bare metal offering. There is a lot of fantastic research and literature that is available in academia, which is hard to productionize.

Artificial Inteligence 202

Artificial Inteligence Machine Learning Open Source Biotech 202